Nebraska Cancer Specialists - Grand Island — Omaha, Nebraska

Nebraska Cancer Specialists - Grand Island is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists - Grand Island has participated in 1 clinical trials.

Therapeutic areas: Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma.

Sponsors: Inhibrx Biosciences, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists - Grand Island?

Nebraska Cancer Specialists - Grand Island has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists - Grand Island conducted?

Nebraska Cancer Specialists - Grand Island has 1 clinical trials on record. Their work covers Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma.

Is Nebraska Cancer Specialists - Grand Island accredited by Crixeo Clinical Trials?

Nebraska Cancer Specialists - Grand Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists - Grand Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.